BRCA1 and neoplasm: Considering the frequencies of the variants observed in our study and the limitations of NGS, we recommend performing a specific blood test for the detection of the three most common variants in our population prior to tumor screening of the entire coding regions of BRCA1 and BRCA2 by NGS.